Key clinical point: A care coordination program can level the playing field for nonwhite patients with diffuse large B-cell lymphoma (DLBCL).
Major finding: Overall survival for patients with relapsed/refractory disease was 74% for whites and 81% for nonwhites.
Study details: Retrospective review of data on 155 white and 41 nonwhite patients with de novo DLBCL.
Disclosures: The study was internally funded. Dr. Ghosh reported consulting fees, research funding, speakers bureau activity, and/or honoraria from multiple companies.
Hu B et al. ASH 2019. Abstract 425.